EGFR and adenocarcinoma: Total mentioned above, it suggested that EGFR mutant SCLCs may have developed from preexisting adenocarcinoma with EGFR mutations, which was consistent with proposing differentiated pluripotent cancer stem cells as the putative origin of SCLC [10, 25].